1 Scott N, "p53 in colorectal cancer: clinicopathological correlation and prognostic significance" 63 (63): 317-319, 1991
2 Gold KA, "Role of molecular markers and gene profiling in head and neck cancers" 21 (21): 206-211, 2009
3 Franchi A, "Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination" 2 (2): 1801-1808, 1996
4 Weinberger PM, "Molecular classification identifies a subset of human papillomavirus: associated oropharyngeal cancers with favorable prognosis" 24 (24): 736-747, 2006
5 Lee SH, "Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma" 145 (145): 64-70, 2011
6 Semczuk A, "Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer" 441 (441): 577-583, 2002
7 Grebe SK, "Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma" 82 (82): 3684-3691, 1997
8 Zou M, "FHIT gene abnormalities in both benign and malignant thyroid tumours" 35 (35): 467-472, 1999
9 Soares P, "E-cadherin gene alterations are rare events in thyroid tumors" 70 (70): 32-38, 1997
10 Naito A, "Clinical significance of E-cadherin expression in thyroid neoplasms" 76 (76): 176-180, 2001
1 Scott N, "p53 in colorectal cancer: clinicopathological correlation and prognostic significance" 63 (63): 317-319, 1991
2 Gold KA, "Role of molecular markers and gene profiling in head and neck cancers" 21 (21): 206-211, 2009
3 Franchi A, "Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination" 2 (2): 1801-1808, 1996
4 Weinberger PM, "Molecular classification identifies a subset of human papillomavirus: associated oropharyngeal cancers with favorable prognosis" 24 (24): 736-747, 2006
5 Lee SH, "Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma" 145 (145): 64-70, 2011
6 Semczuk A, "Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer" 441 (441): 577-583, 2002
7 Grebe SK, "Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma" 82 (82): 3684-3691, 1997
8 Zou M, "FHIT gene abnormalities in both benign and malignant thyroid tumours" 35 (35): 467-472, 1999
9 Soares P, "E-cadherin gene alterations are rare events in thyroid tumors" 70 (70): 32-38, 1997
10 Naito A, "Clinical significance of E-cadherin expression in thyroid neoplasms" 76 (76): 176-180, 2001
11 Roque L, "Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas" 36 (36): 292-302, 2003
12 Kitamura Y, "Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma" 6 (6): 1819-1825, 2000
13 Huiping C, "Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer" 36 (36): 1552-1557, 2000
14 Lee SH, "Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas" 284 (284): 850-855, 2001
15 Nakashima R, "Alteration of p16 and p15 genes in human uterine tumours" 80 (80): 458-467, 1999